Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance

Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance

Inverse vaccines that tolerogenically target antigens to antigen-presenting cells (APCs) offer promise in prevention of immunity to allergens and protein drugs and treatment of autoimmunity. We have previously shown that targeting hepatic APCs through intravenous injection of synthetically glycosyla...

Full description

Bibliographic Details
Main Authors: Chitavi D. Maulloo, Shijie Cao, Elyse A. Watkins, Michal M. Raczy, Ani. S. Solanki, Mindy Nguyen, Joseph W. Reda, Ha-Na Shim, D. Scott Wilson, Melody A. Swartz, Jeffrey A. Hubbell
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
lymph node
subcutaneous
tolerance
glycopolymer
regulatory T cell
dendritic cell
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.714842/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.714842/full

Similar Items